但是FDA还是会允许礼来公司将欣百达作为止痛药在市场上销售。

However, it would allow Lilly to market Cymbalta as a pain treatment.

youdao

FDA称，如果欣百达获得批准，它将是第一个非传统慢性疼痛止痛药。

If approved, the FDA said Cymbalta would be the first nontraditional analgesic approved for chronic pain.

youdao

这项研究针对于用于治疗抑郁症和综合焦虑失调症的度洛西汀或欣百达。

The study looked at the drug duloxetine, or Cymbalta, which is used to treat depression and generalized anxiety disorder.

youdao